Does New Zealand have an innovation system for biotechnology?
, 2002 While there is a large and growing international literature on economic aspects of biotechnology innovation (e.g. work by Carlsson, McKelvey, Orsenigo, Zucker and Darby) these studies concentrate on the United States and Europe.
Marsh, Dan
core
Hazard, risk and responsibility in the current regulation of biotechnology [PDF]
, 2004 Recent events have shown that the release of genetically modified crops and their use as food is increasingly controversial. The confusion over the issues involved displayed by the public, the media and governments across Europe is symptomatic of ...
Mander, Tristan Richard
core
Advanced Healthcare Materials, EarlyView.This study presents a bioengineered assembloid (ASM) system combining glioblastoma (GBM) cells in oxidized alginate (OA) microgels with dorsal organoids (DOs). This model simulates brain tumor‐host interactions, revealing enhanced GBM invasion, altered gene expression, and aggressive infiltration patterns, demonstrating ASM as a valuable platform for ...
Chao Liang +17 more
wiley +1 more source
Biotechnology business in Norway: Peripheral advantage, or just periphery? [PDF]
Research on biotechnology related firms has long been associated with the agglomeration of “dedicated biotechnology firms” and partners such as large corporations, research institutes and venture capital firms.
Terje Grønning
core
Biotechnology and the relationship between university expectations and school provision [PDF]
, 1989 The word ºbiotechnologyº has only come into general use since the publication of the Spinks Report in 1981. There has been uncertainty over its precise meaning, and controversy over the introduction of degree courses entitled ºBiotechnologyº which were ...
Gell, Eileen Ann
core
Advanced Healthcare Materials, EarlyView.A long‐lived, five‐cell‐type human neurovascular (PENTA) model recreates vascular disorganization and incomplete repair after traumatic brain injury (TBI). By integrating endothelial, glial, neuronal, and immune components within a 3D scaffold, the platform enables time‐resolved analysis of neurovascular remodeling and provides a human‐relevant system ...
Daniel S. Hinrichsen +6 more
wiley +1 more source
Does regulation hold the key to optimizing lipopeptide production in Pseudomonas for biotechnology?
Frontiers in Bioengineering and BiotechnologyLipopeptides (LPs) produced by Pseudomonas spp. are specialized metabolites with diverse structures and functions, including powerful biosurfactant and antimicrobial properties.
Lu Zhou +2 more
doaj +1 more source
Industrial Biotechnology Conservation Processes: Similarities with Natural Long-Term Preservation of Biological Organisms. [PDF]
BioTech (Basel), 2023 Laurent A +5 more
europepmc +1 more source
Design and Synthesis of Peptide‐Polyester Conjugates for Cell‐Mediated Scaffold Degradation
Advanced Healthcare Materials, EarlyView.This work describes polycaprolactone (PCL)‐based biomaterials engineered to degrade in response to cell‐secreted proteases. A fast‐degrading peptide (Fast) sequence is integrated into a PCL conjugate backbone to produce a biomaterial that is selectively degraded by multiple cell types compared to its scrambled control (ScrFast).
Korina Vida G. Sinad +7 more
wiley +1 more source
Exploring the Impact of Tensions in Stakeholder Norms on Designing for Value Change: The Case of Biosafety in Industrial Biotechnology. [PDF]
Sci Eng Ethics, 2023 Asin-Garcia E +3 more
europepmc +1 more source